AngioDynamics, Inc. (ANGO)
Largest Insider Buys in Sector
ANGO Stock Price History Chart
ANGO Stock Performance
About AngioDynamics, Inc.
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract …
Insider Activity of AngioDynamics, Inc.
Over the last 12 months, insiders at AngioDynamics, Inc. have bought $202,847 and sold $0 worth of AngioDynamics, Inc. stock.
On average, over the past 5 years, insiders at AngioDynamics, Inc. have bought $516,566 and sold $770,544 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Clemmer James C (President and CEO) — $187,600. Nighan Warren JR (SVP Quality and Regulatory) — $10,570. Trowbridge Stephen A (EVP and CFO) — $9,962.
The last purchase of 100 shares for transaction amount of $608 was made by Nighan Warren JR (SVP Quality and Regulatory) on 2024‑10‑10.
List of Insider Buy and Sell Transactions, AngioDynamics, Inc.
| 2024-10-10 | SVP Quality and Regulatory | 100 0.0002% | $6.08 | $608 | +13.93% | |||
| 2024-10-08 | EVP and CFO | 1,700 0.0033% | $5.86 | $9,962 | +18.88% | |||
| 2024-10-07 | President and CEO | 20,000 0.0399% | $6.03 | $120,600 | +14.59% | |||
| 2024-10-07 | SVP Quality and Regulatory | 768 0.0015% | $6.09 | $4,677 | +14.59% | |||
| 2024-04-08 | President and CEO | 10,000 0.0254% | $6.70 | $67,000 | +3.47% | |||
| 2023-01-31 | Sale | SVP Global Operations and R&D | 4,633 0.0117% | $12.95 | $59,997 | -34.41% | ||
| 2022-10-12 | EVP and CFO | 1,083 0.0027% | $13.82 | $14,967 | -23.49% | |||
| 2022-10-10 | President and CEO | 10,000 0.0264% | $15.00 | $150,000 | -24.76% | |||
| 2022-07-29 | Sale | SVP Global Operations and R&D | 5,000 0.0126% | $22.44 | $112,200 | -43.32% | ||
| 2022-04-28 | Sale | SVP Global Operations and R&D | 3,513 0.009% | $22.44 | $78,832 | -37.25% | ||
| 2022-04-12 | Sale | director | 1,299 0.0034% | $23.26 | $30,215 | -34.97% | ||
| 2022-04-11 | Sale | 7,500 0.0197% | $23.05 | $172,838 | -31.92% | |||
| 2022-01-12 | EVP and CFO | 2,000 0.0052% | $22.64 | $45,280 | -6.16% | |||
| 2022-01-11 | President and CEO | 20,000 0.0498% | $22.84 | $456,800 | -11.60% | |||
| 2021-10-20 | Sale | SVP Global Operations and R&D | 6,988 0.0176% | $27.97 | $195,454 | -21.70% | ||
| 2021-10-15 | Sale | Sr. VP/GM, Global VIT | 24,000 0.0627% | $27.92 | $670,080 | -18.23% | ||
| 2021-10-05 | Sale | SVP/GM, Vascular Access | 21,496 0.0543% | $27.15 | $583,616 | -17.96% | ||
| 2021-04-14 | Sale | SVP Global Operations and R&D | 7,000 0.0182% | $23.93 | $167,510 | +6.62% | ||
| 2021-01-20 | Sale | director | 13,000 0.0335% | $18.53 | $240,890 | +35.77% | ||
| 2020-08-11 | EVP and CFO | 2,026 0.0055% | $9.38 | $19,004 | +123.55% |
Insider Historical Profitability
| Clemmer James C | President and CEO | 681582 1.6774% | $8.69 | 8 | 0 | +14.85% |
| Trowbridge Stephen A | EVP and CFO | 172711 0.425% | $8.69 | 4 | 2 | +31.3% |
| Nighan Warren JR | SVP Quality and Regulatory | 45877 0.1129% | $8.69 | 2 | 0 | |
| HOBBS EAMONN P | President & CEO | 100401 0.2471% | $8.69 | 3 | 27 | +11.48% |
| BUCCI VINCENT | director | 86696 0.2134% | $8.69 | 9 | 0 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $27.49M | 11.69 | 4.68M | -7.17% | -$2.12M | <0.01 | |
| The Vanguard Group | $13.11M | 5.58 | 2.23M | -1.57% | -$209,007.24 | <0.0001 | |
| Systematic Financial Management LLC | $11.43M | 4.86 | 1.95M | +0.75% | +$84,733.46 | 0.32 | |
| Morgan Stanley | $11.02M | 4.68 | 1.88M | -0.51% | -$56,070.26 | <0.01 | |
| Dimensional Fund Advisors | $7.96M | 3.38 | 1.36M | -8.98% | -$784,936.44 | <0.01 |